BSE filing, NSE: RGF. Summary written from the filing by ALFA Finder's alert engine.
RGF Capital Markets Ltd: key numbers
- Share price
- ₹3.46
- Market cap
- ₹51.91 Cr
- Revenue (annual)
- ₹0.54 Cr
- Net profit (annual)
- ₹0.04 Cr
- P/E (TTM)
- -223.8×Sector 19.1×
- Promoter holding
- 16.98%-8.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from RGF Capital Markets Ltd
All →RGF Capital Markets Capital Structure Change
Nishad J. Shah and PACs acquired 2,54,80,900 RGF Capital Markets shares (16.98%) off-market via SPA. The non-promoter buy will trigger an open offer before promoter classification.
RGF Capital Markets Q2 FY27 Results: Net Loss of ₹0.4 Cr
RGF Capital Markets Ltd reported revenue from operations of ₹0.3 Cr and a net loss of ₹0.4 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.4 Cr
RGF Capital Markets Other Announcement
RGF Capital Markets Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI Listing Regulations.
RGF Capital Markets Board Meeting Date
RGF Capital Markets Limited scheduled a board meeting on October 23, 2026, to approve the company's standalone unaudited financial results for the quarter ended September 30, 2026.
RGF Capital Markets Open Offer: ₹4.29 Cr
RGF Capital Markets faces an Open Offer for 26% of shares at ₹1.10 per share. The IDC recommended the offer as fair and reasonable.
- Value
- ₹4.29 Cr
RGF Capital Markets Management Change
RGF Capital Markets appointed Mr. Nishad Jitendra Shah as Managing Director and Mr. Mit Gandhi as CFO. The board also accepted the resignation of Mr. Sagar Mal Nahata.
Other board meeting date announcements
All →Premier Synthetics Board Meeting Date
Premier Synthetics announced its Board of Directors meeting scheduled for 14 November 2026 to consider unaudited Q2 and H1 results. No financial figures or decisions are reported in this advance notice.
HCP Plastene Bulkpack Board Meeting Date
HCP Plastene Bulkpack scheduled a board meeting for 06 November 2026. It will consider unaudited results for the quarter and half year ending 30 September 2026.
Ultracab (India) Board Meeting Date
Ultracab (India) Ltd intimated that its Board meeting is scheduled for 04-Nov-2026 to consider unaudited standalone financial results. No results or financial figures are disclosed in this advance notice.
Texmaco Infrastructure & Holdings Board Meeting Date
Texmaco has scheduled a Board meeting on November 5, 2026, to approve Q2 and H2 FY27 financial results. Trading window stays closed for insiders pending results declaration.
Astonea Labs Board Meeting Date
Astonea Labs intimated that its Board is scheduled on 14 Nov 2026 to consider unaudited half-year results. The trading window remains closed until 48 hours post-announcement.
AstraZeneca Pharma India Board Meeting Date
AstraZeneca Pharma India scheduled its board meeting for 5 Nov 2026 to approve Q2/H1 FY27 results. The trading window remains closed until 7 Nov 2026.